Key points are not available for this paper at this time.
Intravenous flecainide successfully terminated atrial tachycardia in three patients. Maintenance treatment with oral flecainide prevented the recurrence of tachycardia for up to three years. These results suggest an additional use for flecainide which should be further explored.
Creamer et al. (Fri,) studied this question.